272 related articles for article (PubMed ID: 9840022)
1. Oral immunization against Helicobacter pylori--a future concept.
Michetti P
J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
Nyström J; Svennerholm AM
Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
5. [A vaccine against Helicobacter pylori infection].
Presecki V; Katicić M; Kalenić S; Strnad M; Plecko V; Babus V; Dominis M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():79-82. PubMed ID: 12592824
[TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against Helicobacter pylori.
Lee A
J Gastroenterol; 1996 Nov; 31 Suppl 9():69-74. PubMed ID: 8959525
[TBL] [Abstract][Full Text] [Related]
8. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
Zhao W; Wu W; Xu X
Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
[TBL] [Abstract][Full Text] [Related]
10. Development of a vaccine against Helicobacter pylori infection.
Michetti P
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S339-41. PubMed ID: 10077770
[TBL] [Abstract][Full Text] [Related]
11. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
Harbour SN; Every AL; Edwards S; Sutton P
Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
16. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Helicobacter pylori infection.
Lee A
Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
[TBL] [Abstract][Full Text] [Related]
18. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model.
Guo L; Liu K; Zhao W; Li X; Li T; Tang F; Zhang R; Wu W; Xi T
Appl Microbiol Biotechnol; 2013 Mar; 97(6):2367-78. PubMed ID: 23064457
[TBL] [Abstract][Full Text] [Related]
19. The current status of Helicobacter pylori vaccines: a review.
Kabir S
Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
